drugset / Trial / NCT02771158

Midodrine During Recovery From Septic Shock

NCT02771158

Phase 4 Withdrawn Northwell Health
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to determine whether midodrine administration decreases duration of intravenous vasopressors and intensive care unit length of stay for patients in septic shock.

Timeline

Start
2017-08
Primary completion
2017-11-01
Completion
2017-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule 40 mg